Vontobel Holding Ltd. Sells 756 Shares of HCA Healthcare, Inc. $HCA

Vontobel Holding Ltd. trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 13.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,948 shares of the company's stock after selling 756 shares during the quarter. Vontobel Holding Ltd.'s holdings in HCA Healthcare were worth $1,896,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Chung Wu Investment Group LLC bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $27,000. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $26,000. Saudi Central Bank bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $26,000. Finally, WPG Advisers LLC bought a new stake in HCA Healthcare in the 1st quarter valued at $27,000. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on HCA. Weiss Ratings restated a "buy (b-)" rating on shares of HCA Healthcare in a research note on Wednesday. Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 7th. Royal Bank Of Canada dropped their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Finally, KeyCorp lifted their price objective on HCA Healthcare from $370.00 to $465.00 and gave the company an "overweight" rating in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat.com, HCA Healthcare has an average rating of "Moderate Buy" and a consensus target price of $422.31.

HCA Healthcare Trading Down 1.0%

NYSE HCA opened at $414.73 on Friday. The business's 50-day moving average price is $405.12 and its two-hundred day moving average price is $375.85. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01. The firm has a market capitalization of $97.04 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the previous year, the company posted $5.50 EPS. The business's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.